• 0
    Loading cart contents...
Search
Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T124a
Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T124a
UBD243
BioCoreUSA row: 3; column: 8; cores: 24; cases: 12
Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T121
Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T121
UBD241
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Bladder cancer with bladder tissue array, including pathology grade, TNM and clinical stage, 191 cases/192 cores, replacing BL2081b
Bladder cancer with bladder tissue array, including pathology grade, TNM and clinical stage, 191 cases/192 cores, replacing BL2081b
BL2081c
BioCoreUSA row: 12; column: 16; cores: 192; cases: 191
Bladder cancer and bladder tissue array, including pathology grade, TNM and clinical stage, 66 cases/80 cores, replacing BL806b
Bladder cancer and bladder tissue array, including pathology grade, TNM and clinical stage, 66 cases/80 cores, replacing BL806b
UBD806c
BioCoreUSA row: 8; column: 10; cores: 80; cases: 66
Bladder cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 10 cases/24 cores, replacing BL241
Bladder cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 10 cases/24 cores, replacing BL241
BL241a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 10
Bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 27 cases/81 cores
Bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 27 cases/81 cores
UBD812
BioCoreUSA row: 9; column: 9; cores: 81; cases: 27
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
UBD208a
BioCoreUSA row: 12; column: 16; cores: 192; cases: 64
Multiple of bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 90 cases/90 cores
Multiple of bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 90 cases/90 cores
UBD902
BioCoreUSA row: 9; column: 10; cores: 90; cases: 90
Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores
Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores
UBD1501
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores
Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores
BL482
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores
Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores
UBD244
BioCoreUSA row: 4; column: 6; cores: 24; cases: 6
Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/24 cores
Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/24 cores
UBD242
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248
BR248a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 24
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483
FMG483b
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b
FMG483c
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BL805
Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BL805
BL805a
BioCoreUSA row: 8; column: 10; cores: 80; cases: 80
Different stages bladder cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 27 cases/54 cores
Different stages bladder cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 27 cases/54 cores
UBD541
BioCoreUSA row: 7; column: 8; cores: 54; cases: 27
Bladder cancer (stage III-IV) tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores
Bladder cancer (stage III-IV) tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores
UBD601
BioCoreUSA row: 6; column: 10; cores: 60; cases: 60
Bladder cancer tissue array with cancer adjacent tissue, including TNM and clinical stage, 12 cases/24 cores, replacing BL243
Bladder cancer tissue array with cancer adjacent tissue, including TNM and clinical stage, 12 cases/24 cores, replacing BL243
UBD243a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 12
Bladder cancer tissue array, including TNM and clinical stage, 208 cases/208 cores, replacing BL2082a
Bladder cancer tissue array, including TNM and clinical stage, 208 cases/208 cores, replacing BL2082a
UBD2082b
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c
FBR087d
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Middle-advanced stage bladder cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores
Middle-advanced stage bladder cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores
UBD1921
BioCoreUSA row: 12; column: 16; cores: 192; cases: 96
Bladder cancer (stage III-IV) tissue array, including TNM and clinical stage, 60 cases/60 cores, replacing BL601a
Bladder cancer (stage III-IV) tissue array, including TNM and clinical stage, 60 cases/60 cores, replacing BL601a
UBD601b
BioCoreUSA row: 6; column: 10; cores: 60; cases: 60
Bladder cancer (stage III-IV) tissue array, including TNM and clinical stage, 60 cases/60 cores, replacing BL601b
Bladder cancer (stage III-IV) tissue array, including TNM and clinical stage, 60 cases/60 cores, replacing BL601b
BL601c
BioCoreUSA row: 6; column: 10; cores: 60; cases: 60
Breast cancer tissue array with matched adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251
Breast cancer tissue array with matched adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251
FMG251a
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e
FMG08013f
BioCoreUSA row: 8; column: 9; cores: 72; cases: 72
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b
BR2085c
BioCoreUSA row: 13; column: 16; cores: 208; cases: 188
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 4 cases/8 cores, replacing BR082
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 4 cases/8 cores, replacing BR082
FMG082a
BioCoreUSA row: 2; column: 4; cores: 8; cases: 4
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b
Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b
BR1504c
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a
BR1006b
BioCoreUSA row: 10; column: 10; cores: 100; cases: 50
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505e
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505e
BR1505f
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505b
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505b
FMG1505c
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR484a
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR484a
BR484b
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BC08015
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BC08015
BR728
BioCoreUSA row: 8; column: 9; cores: 72; cases: 24
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BRC962
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BRC962
BR965
BioCoreUSA row: 8; column: 12; cores: 96; cases: 48
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR803a
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR803a
FMG803b
BioCoreUSA row: 8; column: 10; cores: 80; cases: 80
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d
FMG08013e
BioCoreUSA row: 8; column: 9; cores: 72; cases: 72
Bladder cancer with bladder tissue array (2016 WHO classification), including pathology grade, TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores
Bladder cancer with bladder tissue array (2016 WHO classification), including pathology grade, TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores
BLA501
BioCoreUSA row: 6; column: 9; cores: 50; cases: 50
Bladder cancer tissue array with normal tissue, including TNM and clinical stage, 40 cases/80 cores
Bladder cancer tissue array with normal tissue, including TNM and clinical stage, 40 cases/80 cores
UBD803
BioCoreUSA row: 8; column: 10; cores: 80; cases: 40
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c
BR251d
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b
FMG251c
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Bladder cancer tissue array with bladder tissue, including TNM and pathology grade, 81 cases/81 cores
Bladder cancer tissue array with bladder tissue, including TNM and pathology grade, 81 cases/81 cores
UBD811
BioCoreUSA row: 9; column: 9; cores: 81; cases: 81
Bone tumor test tissue array with normal tissue as control, including TNM, clinical stage, 12 cases/24 cores, replacing T262
Bone tumor test tissue array with normal tissue as control, including TNM, clinical stage, 12 cases/24 cores, replacing T262
LBN262a
BioCoreUSA row: 3; column: 8; cores: 24; cases: 12
Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008
Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008
BR1008a
BioCoreUSA row: 10; column: 10; cores: 100; cases: 100
Multiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003a
Multiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003a
FMG1003b
BioCoreUSA row: 10; column: 11; cores: 101; cases: 47
Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores
Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores
UBD721
BioCoreUSA row: 8; column: 9; cores: 72; cases: 24
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores
FMG1009
BioCoreUSA row: 10; column: 10; cores: 100; cases: 50
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores
FMG809
BioCoreUSA row: 8; column: 10; cores: 80; cases: 80
Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 54 cases/80 cores, replacing BR802b
Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 54 cases/80 cores, replacing BR802b
FMG802c
BioCoreUSA row: 8; column: 10; cores: 80; cases: 54
Breast cancer tissue array (most of triple negative), including pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing BR1202a
Breast cancer tissue array (most of triple negative), including pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing BR1202a
BR1202b
BioCoreUSA row: 10; column: 12; cores: 120; cases: 60